U.S., General Motors Settle Alleged Discrimination Against Non-US Citizens

U.S., General Motors Settle Alleged Discrimination Against Non-US Citizens

WASHINGTON (Reuters) – The U.S. Justice Department on Tuesday said it had reached a settlement with General Motors Co to resolve the department’s determination that the American automaker discriminated against non-U.S. citizens. Under the terms of the agreement, the company will pay $365,000 in civil penalties to the United States, the Justice Department said in…

Read More
FTX Revival Effort Draws Possible Bid From VC Firm Tribe Capital - Bloomberg News

FTX Revival Effort Draws Possible Bid From VC Firm Tribe Capital – Bloomberg News

(Reuters) -Bankrupt crypto exchange FTX’s potential revival has drawn interest from venture firm Tribe Capital, Bloomberg News reported on Tuesday citing people familiar with the matter. Tribe is considering leading a $250 million fund-raising campaign, anchored by $100 million from itself and its limited partners, the report said citing one of the people. Bahamas-based FTX…

Read More
US Single-family Housing Starts Rise Further; Building Permits Surge

US Single-family Housing Starts Rise Further; Building Permits Surge

By Lucia Mutikani WASHINGTON (Reuters) -U.S. single-family homebuilding increased for a second straight month in March, while permits for future construction surged, offering some glimmers of hope for the depressed housing market ahead of the busy spring selling season. Single-family housing starts, which account for the bulk of homebuilding, rose 2.7% to a seasonally adjusted…

Read More
AstraZeneca Confident New COVID Antibody Protects Against Known Variants

AstraZeneca Confident New COVID Antibody Protects Against Known Variants

By Maggie Fick BARCELONA (Reuters) – AstraZeneca is confident that its new version of COVID-19 antibody treatment could protect immunocompromised patients against all known virus variants, its vaccines head said. Laboratory studies show the antibody, called AZD3152, neutralizes all known variants of COVID-19 and AstraZeneca has support from regulators to make the treatment available by…

Read More